- Home
- MTEN vs COEP Comparison
MTEN vs COEP Comparison
Compare MTEN & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEN
- COEP
- Stock Information
- Founded
- MTEN 2015
- COEP 2017
- Country
- MTEN China
- COEP United States
- Employees
- MTEN N/A
- COEP N/A
- Industry
- MTEN Building Products
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MTEN Industrials
- COEP Health Care
- Exchange
- MTEN Nasdaq
- COEP Nasdaq
- Market Cap
- MTEN 82.6M
- COEP 62.4M
- IPO Year
- MTEN 2024
- COEP N/A
- Fundamental
- Price
- MTEN $11.75
- COEP $12.57
- Analyst Decision
- MTEN
- COEP
- Analyst Count
- MTEN 0
- COEP 0
- Target Price
- MTEN N/A
- COEP N/A
- AVG Volume (30 Days)
- MTEN 59.0K
- COEP 40.0K
- Earning Date
- MTEN 10-18-2025
- COEP 11-12-2025
- Dividend Yield
- MTEN N/A
- COEP N/A
- EPS Growth
- MTEN N/A
- COEP N/A
- EPS
- MTEN N/A
- COEP N/A
- Revenue
- MTEN $10,120,257.00
- COEP $263,555.00
- Revenue This Year
- MTEN N/A
- COEP N/A
- Revenue Next Year
- MTEN N/A
- COEP N/A
- P/E Ratio
- MTEN N/A
- COEP N/A
- Revenue Growth
- MTEN 23.03
- COEP N/A
- 52 Week Low
- MTEN $3.20
- COEP $2.31
- 52 Week High
- MTEN $26.03
- COEP $14.70
- Technical
- Relative Strength Index (RSI)
- MTEN 43.04
- COEP 51.06
- Support Level
- MTEN $11.47
- COEP $12.09
- Resistance Level
- MTEN $12.75
- COEP $13.25
- Average True Range (ATR)
- MTEN 0.84
- COEP 0.68
- MACD
- MTEN 0.07
- COEP -0.12
- Stochastic Oscillator
- MTEN 56.92
- COEP 45.47
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.